NCT06675916

Brief Summary

After hip arthroplasty, pain intensity is maximum within the first 6 hours and is then estimated to last between 36 and 72 hours. Pain management (analgesia) after hip prosthetic surgery remains a challenge. A bad analgesic treatment can result in delay in mobilization/ambulation and thus increase duration of patient's stay which can have a significant economic impact. The different recognized analgesia techniques (intra-articular infiltration and peripheral nerve blocks) are effective but have shown certain limits. A new peripheral nerve block, the PENG block has shown very encouraging results on postoperative analgesia quality. In this context, this research is based on the hypothesis that ultrasound-guided PENG block could provide more effective analgesia than intra-articular infiltration during mini-invasive anterior hip prosthesis surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2023

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

June 3, 2024

Completed
5 months until next milestone

First Posted

Study publicly available on registry

November 5, 2024

Completed
Last Updated

November 5, 2024

Status Verified

November 1, 2024

Enrollment Period

1.1 years

First QC Date

June 3, 2024

Last Update Submit

November 4, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Morphine dose

    Primary outcome measure is the total morphine quantity administered intraoperatively, in milligrams

    1 day

Secondary Outcomes (4)

  • Pain level

    Day 0, 1, 7 and 45

  • Patient quality of life

    Day 1, 7 and 45

  • Hip symptoms and limitations

    Day 45

  • Hip impact on daily life

    Day 45

Study Arms (2)

PENG block

EXPERIMENTAL

Total hip prosthesis with infiltration of lidocaine hydrochloride by ultrasound-guided PENG block

Procedure: PENG Block with lidocaine hydrochloride

Intra-articular infiltration

ACTIVE COMPARATOR

Total hip prosthesis with intra-articular infiltration of lidocaine hydrochloride

Procedure: Intra-articular infiltration with lidocaine hydrochloride

Interventions

Intervention is ultrasound-guided PENG block analgesia with lidocaine hydrochloride

PENG block

Intervention is intra-articular analgesia with lidocaine hydrochloride

Intra-articular infiltration

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient, male or female, over 18 years old.
  • Patient scheduled for hip prosthesis placement via the anterior approach

You may not qualify if:

  • Patient with local anesthesia contraindication.
  • Patient with a high level of dependency, defined by level 1 or 2 of Iso Ressources Group (GIR).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Médipôle Hôpital Privé

Villeurbanne, 69100, France

Location

MeSH Terms

Conditions

Agnosia

Interventions

Lidocaine

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 3, 2024

First Posted

November 5, 2024

Study Start

March 1, 2022

Primary Completion

March 31, 2023

Study Completion

March 31, 2023

Last Updated

November 5, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations